CompletedNot Applicable

Myocardial Involvement of Severe Acute Respiratory Syndrome-Cov-2 (Covid19) Infected Patients

France122 participantsStarted 2020-04-04

Plain-language summary

The effects of severe acute respiratory syndrome SARS-Cov-2 (Covid-19) on the myocardium and their role in the clinical course of infected patients are still unknown. Epidemiological studies report biological myocardial involvement in 10 to 25% of cases. The objective of this study is to cardiac phenotype using comprehensive cardiac imaging tools of patients infected with Covid 19 in order to explore the functional impact of the infection on the myocardium.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Major patients hospitalized for respiratory criteria for SARS-Cov-2 infection confirmed by RT-PCR Exclusion Criteria: * Underage patients. Patients refusing to participate in research. Patients with a history of heart disease.

What they're measuring

Left ventricular function

Timeframe: Day 0

Left ventricular function

Timeframe: Day 3

Left ventricular function

Timeframe: Day 7

Trial details

NCT IDNCT04358952

SponsorUniversity Hospital, Toulouse

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2021-04-02

View on ClinicalTrials.gov More Cardiomyopathies trials